Mark Watson
About Mark Watson
Mark Watson is the Senior Director of Manufacturing Technology and Development at Lantheus Medical Imaging and Director of Technology Support and Development at Bristol-Myers Squibb, with a strong background in regulatory compliance, technology transfer, and patient safety.
Company
Mark Watson is currently working at two notable organizations in the medical and pharmaceutical industry. He holds the position of Senior Director, Manufacturing Technology and Development at Lantheus Medical Imaging in North Billerica, Massachusetts, United States. Additionally, he serves as Director, Technology Support and Development at Bristol-Myers Squibb in New Jersey, United States.
Title
Mark Watson is the Director of Technology Support and Development at Bristol-Myers Squibb, and also serves as the Senior Director of Manufacturing Technology and Development at Lantheus Medical Imaging.
Education and Expertise
Mark Watson studied Chemistry at the University of Minnesota, where he achieved a Doctor of Philosophy degree, completing his studies from 1977 to 1981. He specializes in various aspects of technology and manufacturing within the medical field, including regulatory filings and approvals, technology transfer, and manufacturing site qualifications.
Work Background
With over 16 years of experience at Lantheus Medical Imaging, Mark Watson has developed extensive expertise in regulatory filings, compliance, and technology transfer. He has a proven track record of facilitating smooth transitions and operational efficiency within manufacturing sites.
Commitment to Patient Safety
Mark Watson is dedicated to patient safety and public health. He works closely with physicians to determine the best course of action for patients seeking access to investigational medicines and ensures these medicines are provided in a fair and equitable manner. His robust system handles pre-approval access requests from physicians, ensuring investigational medicines are only provided when no other viable treatment options are available.